$WVE
Wave Life Sciences Ltd.

2016 Q1 Form 10-Q Financial Statement

#000156459017010229 Filed on May 10, 2017

View on sec.gov

Income Statement

Concept 2016 Q1
Revenue $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.220M
YoY Change 71.28%
% of Gross Profit
Research & Development $4.736M
YoY Change 194.71%
% of Gross Profit
Depreciation & Amortization $153.0K
YoY Change 70.0%
% of Gross Profit
Operating Expenses $7.952M
YoY Change 127.79%
Operating Profit -$7.952M
YoY Change 129.49%
Interest Expense $104.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net $100.0K
YoY Change 100.0%
Pretax Income -$7.852M
YoY Change 129.93%
Income Tax -$5.000K
% Of Pretax Income
Net Earnings -$7.847M
YoY Change 126.46%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$364.3K
COMMON SHARES
Basic Shares Outstanding 21.55M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $153.4M
YoY Change
Cash & Equivalents $153.4M
Short-Term Investments
Other Short-Term Assets $600.0K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $154.0M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $3.218M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.300M
YoY Change
Total Long-Term Assets $4.522M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $154.0M
Total Long-Term Assets $4.522M
Total Assets $158.5M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.437M
YoY Change
Accrued Expenses $1.300M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $100.0K
YoY Change
Total Short-Term Liabilities $3.770M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $100.0K
YoY Change
Other Long-Term Liabilities $295.0K
YoY Change
Total Long-Term Liabilities $357.0K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.770M
Total Long-Term Liabilities $357.0K
Total Liabilities $4.127M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$42.92M
YoY Change
Common Stock $185.3M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $146.5M
YoY Change
Total Liabilities & Shareholders Equity $158.5M
YoY Change

Cashflow Statement

Concept 2016 Q1
OPERATING ACTIVITIES
Net Income -$7.847M
YoY Change 126.46%
Depreciation, Depletion And Amortization $153.0K
YoY Change 70.0%
Cash From Operating Activities -$7.140M
YoY Change 340.74%
INVESTING ACTIVITIES
Capital Expenditures $685.0K
YoY Change 3929.41%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$690.0K
YoY Change 885.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -20.00K
YoY Change -100.17%
NET CHANGE
Cash From Operating Activities -7.140M
Cash From Investing Activities -690.0K
Cash From Financing Activities -20.00K
Net Change In Cash -7.850M
YoY Change -178.97%
FREE CASH FLOW
Cash From Operating Activities -$7.140M
Capital Expenditures $685.0K
Free Cash Flow -$7.825M
YoY Change 378.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 wve Amortization Of Lease Incentive Obligation
AmortizationOfLeaseIncentiveObligation
17000
CY2017Q1 us-gaap Depreciation
Depreciation
315000
CY2016Q1 us-gaap Depreciation
Depreciation
153000
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2999000
CY2016Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
866000
CY2017Q1 us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
1031000
CY2016Q1 us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
136000
CY2016Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-5000
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1813000
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
414000
CY2016Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
53000
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1017000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-296000
CY2017Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-537000
CY2017Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3000
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-72000
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
221000
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19693000
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1303000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-20996000
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.89
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
23531788
CY2017Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
15000
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20981000
CY2016Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
329000
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-676000
CY2017Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1259000
CY2016Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-5000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-17418000
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-7136000
CY2017Q1 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
3000
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3635000
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
685000
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3638000
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-685000
CY2017Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
16000
CY2016Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
16000
CY2017Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
206000
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
190000
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-16000
CY2017Q1 us-gaap Effect Of Exchange Rate On Cash Continuing Operations
EffectOfExchangeRateOnCashContinuingOperations
57000
CY2016Q1 us-gaap Effect Of Exchange Rate On Cash Continuing Operations
EffectOfExchangeRateOnCashContinuingOperations
14000
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-20809000
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7823000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
161220000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
153397000
CY2017Q1 wve Lease Incentive Obligations Incurred
LeaseIncentiveObligationsIncurred
1082000
CY2017Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2976000
CY2016Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
185000

Files In Submission

Name View Source Status
0001564590-17-010229-index-headers.html Edgar Link pending
0001564590-17-010229-index.html Edgar Link pending
0001564590-17-010229.txt Edgar Link pending
0001564590-17-010229-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wve-10q_20170331.htm Edgar Link pending
wve-20170331.xml Edgar Link completed
wve-20170331.xsd Edgar Link pending
wve-20170331_cal.xml Edgar Link unprocessable
wve-20170331_def.xml Edgar Link unprocessable
wve-20170331_lab.xml Edgar Link unprocessable
wve-20170331_pre.xml Edgar Link unprocessable
wve-ex311_14.htm Edgar Link pending
wve-ex312_8.htm Edgar Link pending
wve-ex32_10.htm Edgar Link pending